To determine the expression profiles of Cdc42 (gene: CDC42) and Arp2 (gene: ACTR2) across various cancer types, we performed a gene expression analysis utilizing the GEPIA (Gene Expression Profiling Interactive Analysis) platform based on tumor and normal samples from the TCGA and the GTEx databases [53]. This evidence concerns the gene ACTR2 and neoplasm.